ruthenium has been researched along with amobarbital in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Cominetti, MR; Correa, RS; de Oliveira, KM; Ellena, J; Godoy, LR; Graminha, AE; Honorato de Araujo-Neto, J; Popolin, C; Vegas, LC | 1 |
1 other study(ies) available for ruthenium and amobarbital
| Article | Year |
|---|---|
New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
Topics: Aminosalicylic Acid; Amobarbital; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Neoplasms; Phosphorus; Ruthenium; Salicylic Acid | 2022 |